Description
| Product Name | CAT.No | Details |
| Glucose-6-Phosphate Dehydrogenase (G6PDH) (Lyo.) | BXC0571A | R1: 2 x 50ml R2: 1 x 2ml R3:1 x 2ml |
| Glucose-6-Phosphate Dehydrogenase (G6PDH) (Lyo.) | BXC0574C | 100T |
Product Description
The Biorex Diagnostics Glucose-6-Phosphate Dehydrogenase (G6PD) Test is a high-quality neonatal screening assay developed for the early detection of G6PD deficiency, a common inherited enzyme disorder that affects the stability and lifespan of red blood cells. Early identification of this enzyme deficiency is critical, as it can lead to hemolytic anemia and other complications if left undiagnosed. The Biorex G6PD Test provides laboratories, hospitals, and large-scale newborn screening programmes with a simple, reliable, and highly sensitive tool to identify at-risk infants and enable timely clinical intervention.
Key Features
- Neonatal-Friendly Sampling: Compatible with dried blood spots, serum, or plasma, allowing minimally invasive collection methods suitable for newborns.
- Accurate Enzyme Quantification: Measures G6PD activity precisely, enabling detection of both partial and complete enzyme deficiencies for reliable diagnosis.
- Rapid and Reliable Results: Provides fast, reproducible measurements to support timely clinical decision-making and early preventive care.
- High Sensitivity and Specificity: Detects subtle variations in enzyme activity, reducing the likelihood of false negatives or false positives.
- User-Friendly Workflow: Minimal preparation steps and a straightforward procedure make the test suitable for high-throughput screening in busy laboratory environments.
- Laboratory Integration: Fully compatible with standard laboratory platforms and LIMS, enabling seamless incorporation into existing workflows.
- Cost-Effective Solution: Designed for large-scale neonatal screening, offering an economical option without compromising accuracy or reliability.
Benefits
The Biorex G6PD Test provides a trusted and clinically relevant solution for neonatal screening, combining precision, reliability, and ease of use. By enabling early detection of enzyme deficiency, healthcare providers can implement timely interventions, preventing hemolytic crises and supporting improved long-term outcomes. Its ready-to-use reagents, robust methodology, and scalable workflow make the assay ideal for both routine hospital testing and population-wide screening programmes.
With its combination of accuracy, efficiency, and operational simplicity, the Biorex G6PD Test allows laboratories to deliver consistent, reproducible results while supporting optimal patient care and preventive health strategies for infants.
Contact Us for more information.